Abstract: Glycosylated antitumor ether lipids (GAELs) have superior anticancer properties relative to the alkyllysophospholipid class, but there have been no studies of the mechanisms of these compounds. The prototype GAEL, 1-O-hexadecyl-2-O-methyl-3-O-(2'-amino-2'-deoxy-b-D-glucopyranosyl)-sn-glycerol (Gln), effectively killed mouse embryonic fibroblasts (MEFs) lacking key molecules involved in caspase-dependent apoptosis, and cell death was not prevented by caspase inhibitors. Gln did not cause a loss of mitochondrial membrane potential, even in rounded-up dying cells. Gln stimulated the appearance and accumulation of LC3-II, a protein marker for autophagy, in a variety of cells, including wild-type MEFs, but not in MEFs lacking ATG5, a key protein required for autophagy. Gln induced LC3 puncta formation in Chinese hamster ovary cells stably expressing a LC3-green fluorescent protein fusion protein. Thus, Gln appears to induce autophagy. Autophagy was mTOR-independent and was not inhibited by 3-methyladenine or wortmannin. Although Gln is toxic, cellular ability to undergo autophagy was not essential for its toxicity. Furthermore, the GAEL analog 2-deoxy-C-Glc induced LC3 puncta formation but did not kill the cells. Gln, but not 2-deoxy-C-Glc, caused the accumulation of cytoplasmic acidic vacuoles in the cells. Our data suggest that GAELs may activate autophagy; however, GAELs do not kill cells by apoptosis or autophagy but rather by a paraptosis-like cell death mechanism.
Introduction
Antitumor ether lipids (AELs) are lipids with anticancer properties that are characterized by the presence of ether bonds at the sn-1 and sn-2 positions of the glycerol backbone (Lohmeyer and Bittman 1994) . The presence of 2 ether bonds in the molecules makes them resistant to metabolism and gives them a long half-life. AELs have the potential to deliver antitumor activity without any mutagenicity because, unlike many other anticancer agents, they do not interact directly with DNA. Alkyllysophospholipids (ALPs) are analogs of lysophosphatidylcholine and are typified by 1-Ooctadecyl-2-O-methyl-glycerophosphocholine (ET-18-OCH 3 , Structure 1), the best known and most extensively studied AEL. ALPs possess cell-selective effects by inhibiting cell proliferation and are toxic to cancer cells at concentrations that do not affect normal cells (Berdel 1991; Samadder and Arthur 1999) . AELs with a fatty alkyl group (C16 or C18) at the sn-1 position, a methoxy group at the sn-2 position, and a glycosyl moiety linked via an O or S bond at the sn-3 position of glycerol represent another class of these compounds and are collectively classified as glycosylated AELs (GAELs). One advantage of replacing the phosphocholine group of ALPs with a glycosyl unit is that GAELs are less thrombogenic than ALPs (Guivisdalsky et al. 1990) .
GAELs are effective against a wide range of cancer cells. Substitution of a 2-deoxyglucopyranosyl moiety at the sn-3 position yielded a GAEL that was potent in its antiproliferative effect on MCF-7 cells and adriamycin-resistant MCF-7 cells (Marino-Albernas et al. 1996) . A GAEL with a 2'-amino-2'-deoxyglucopyranosyl moiety at the sn-3 position of glycerol, 1-O-hexadecyl-2-O-methyl-3-O-(2'-amino-2'-deoxy-b-D-glucopyranosyl)-sn-glycerol (Gln), had a high activity (IC 50 4 mmol/L) on the proliferation of NIH OVCAR-3, an ovarian cancer cell line that is resistant to adriamycin, mephalan, and cisplatin (Erukulla et al. 1996) . ET-18-OCH 3 and alkylphosphocholines (hexadecylphosphocholine and octadecylphosphocholine) were much less effective (IC 50 >24 mmol/L). ET-16-OCH 3 -Gln and its thio analog, ET-16-OCH 3 -S-Gln, were much more potent against non-transformed and oncogene-transformed fibroblasts (3T3 clone 7) than several phosphocholine-and phosphonocholine-containing AELs (Samadder et al. 1998 ). These striking differences in the cell selectivity profiles suggest that the mechanism of action of GAELs may be distinct from that of AELs.
Studies on the mechanism of action of ALPs indicate that multiple targets may be responsible for the antitumor action of these compounds. They act by perturbing intracellular signaling pathways that lead to growth inhibition and (or) cell death Bittman and Arthur 1999) . ET-18-OCH 3 kills cells by activating apoptosis, but the means of achieving this may differ in various cell types. Perturbation of mitogen activated protein kinase, phosphoinositide 3-kinase, and Jun NH 2 -terminal kinase pathways have been reported in different cell types Gajate et al. 1998; Samadder et al. 2004; Ruiter et al. 2003) . In addition, a mechanism involving activation of the Fas/ CD95 pathway has been reported in leukemic cells (reviewed in Mollinedo et al. 2004 ). Indeed, Fas/ CD95-independent cell death by liposomal ET-18-OCH 3 was reported (Cuvillier et al. 1999) .
The mechanism of action of GAELs is completely unexplored. It is not even known if these compounds kill cells by activating apoptosis. In this study, we have investigated the mechanism of action of GAELs. Our results show that GAELs induce autophagy but that cell death was not a result of autophagy. Rather, it appears to arise via a paraptosis-like mechanism.
Materials and methods

Materials
LC3 antibodies were generously provided by Dr. Yoshimori (National Institute of Genetics, Mishima, Shizouka, Japan) and were also obtained commercially from Novus Biological (NB 100-2220; Littleton, Colorado). Actin antibodies were from Santa Cruz, California. Phospho S6 protein and phospho 4E-BP1 antibodies were from Cell Signaling (Pickering, Ontario); CaspGLOW caspase staining kits were obtained from Biovision (Mountain View, California). Acridine orange, ethidium bromide, 3-methyladenine (3-MA), chloroquine phosphate, and bafilomycin were purchased from Sigma. The CyQuant proliferation kit, cell media, Prolong Gold, Lysotracker Red DND, and subculture reagents were from Invitrogen. The ToxiLight cytotoxic kit was obtained from Lonza Rockland Inc. (Rockland, Maine). The JC-1 mitochondrial membrane detection kit was obtained from Strategene (La Jolla, California). ET-18-OCH 3 was obtained from MedMark (Gruenwald, Muenchen, Germany). Gln and 2-deoxy-C-Glc were synthesized as previously described (Erukulla et al. 1996; Yang et al. 1999) .
Cell culture
Mammalian cancer cell lines were grown from frozen stocks originally obtained from American Type Culture Collection. BT549 was grown in RPMI medium, and A549 was grown in F12 medium. MDA-MB-231 was grown in MEM with non-essential amino acids and DU145 was grown in DMEM. Mouse embryonic fibroblasts, Apaf1 null (-/-), caspase 3 null (-/-), ASK1 null (-/-), caspase 9 null (-/-) (from Dr. Tak Mak, University of Toronto, Toronto, Ontario), ATG5 wild type, ATG5 null (-/-) (from Dr. N. Mizushima, Tokyo Dental and Medical University, Tokyo, Japan), and Ask1 null (-/-) cells (from Dr. H. Ichijo, University of Tokyo, Tokyo, Japan) were grown in DMEM. Chinese hamster ovary (CHO) green fluorescent protein (GFP)-LC3 (CHO-GFP-LC3) cells were obtained from Dr. Z. Elazar (Weizmann Institute of Science, Rehovot, Israel) and were grown in alpha MEM medium. All cells were grown in their respective media supplemented with 10% FBS, penicillin, and streptomycin.
Proliferation assays
Cells were dispersed into 48-well plates and incubated until they were in the log phase. The effect of ether lipids on the proliferation of cells was assessed by determining the increase in cell number relative to the increase in control cells using a Coulter ZM counter as previously described (Bittman et al. 2007 ). Proliferation was also assessed in some experiments by use of the CyQuant assay as previously described (Bittman et al. 2007 ).
Toxicity assays
The toxicity of the compounds was measured using the ToxiLight assay kit according to the instructions of the manufacturer. Equal numbers of cells were dispersed into clearbottomed 96-well white-walled plates. When the cells were in log-phase growth, different concentrations of the drugs were added in duplicate rows. At the end of the 48 h incubation, 100% ToxiLight lysis solution was added to 1 row of each set of concentrations to lyse all of the cells and provide a reference value for the total adenylate kinase activity in the group. Equal volumes of the lysis solution buffer or Tris-acetate, supplied with the kit, were added to the experimental group. After a 15 min incubation to ensure complete lysis, the adenylate kinase reagents were added to each well, and the light emitted was measured by use of a luminometer (Fluoroscan FL plate reader). The cytotoxicity of the compound is expressed as the % of the adenylate kinase activity in the medium relative to the total activity in the lysed group (medium and cells).
Caspase activation
The activation of caspases in the cells was monitored by use of the CaspGLOW fluorescein caspase staining kit. When cells were in the log phase, the medium was removed and replaced with medium containing the test compound or ethanol (control). After 20 h, the cells were detached with trypsin and aliquots were taken for the determination of cell numbers using a Coulter counter. The cells were pelleted and resuspended in fresh medium at a density of 1 Â 10 6 cells/mL. Aliquots (300 mL) were incubated with the FITC-Z-VAD-FMK reagent for 1 h at 37 8C in a CO 2 incubator. The cells were pelleted, washed twice, resuspended in buffer, transferred to black microtiter plates, and analyzed by use of a Fluoroscan FL plate reader (excitation 485 nm, emission 535 nm).
Western blot analysis
Cells were treated with Gln, and lysates were obtained with lysis buffer as previously described . Protein levels were determined by use of the Coomassie Blue assay (BioRad), and equal amounts of proteins were separated by SDS-PAGE and transferred to nitrocellulose membranes. The primary antibodies used were anti-LC3, anti-actin, anti-phospho-S6 ribosomal protein (Ser 235/236), and anti-phospho 4E-BP1 (Thr 37/46). Signals were detected with anti-IgG-HRP with chemiluminescence reagents.
Immunofluorescence
CHO cells expressing GFP-LC3 were grown on cover slips and treated with the compounds as described in the Results section. The cells were washed with PBS and fixed with freshly prepared 4% paraformaldehyde in PBS for 20 min. The cells were then washed 3 times with PBS and subsequently incubated in 50 mmol/L NH 4 Cl for 10 min. The cells were washed twice in PBS and twice in filtered double-distilled water prior to mounting on a slide with ProlongGold. Lysotracker Red DND staining was carried out as described by the manufacturer. Cells were fixed and observed with a fluorescence microscope using the appropriate optics. Fluorescent images were taken with either an Olympus IX70 fluorescent microscope equipped with a Spot RT camera (100Â images), or a CarlZeiss AxioImager upright microscope (63Â images). Images were processed with ImagePro plus software.
Acridine orange staining
Cells were grown in dishes and incubated with Gln. Subsequently, acridine orange (1 mg/mL) in growth medium was added, and the cells were incubated for 15 min at 37 8C (Daido et al. 2004 ). For fluorescence analysis, the cells were washed 3 times with PBS, incubated with PBS, and viewed under a fluorescence microscope.
Mitochondrial membrane potential assay
Cells were grown on cover slips and incubated with or without GAELs for specified times. The mitochondrial membrane potential was measured with the JC-1 assay according to the manufacturer's instructions for monolayer cells. JC-1 is a dye that changes colour from red to green as the membrane potential decreases. In healthy cells, the dye exists as a monomer in the cytosol and accumulates as it aggregates in the mitochondria, which stain red. Collapse of the mitochondrial membrane in apoptotic cells results in the loss of red mitochondrial staining, with the JC-1 reagent remaining in the cytosol in a green fluorescent monomeric form (Smiley et al. 1991; Cossarizza et al. 1993) .
Results
Gln-induced cell death is not via caspase-dependent apoptosis
ET-18-OCH 3 , the prototype AEL (Structure 1), kills cells via apoptosis (Gajate et al. 1998; Ruiter et al. 2003; Cuvillier et al. 1999) . To investigate if Gln also killed cells by apoptosis, we compared the ability of Gln and ET-18-OCH 3 to inhibit growth and kill mouse embryonic fibroblasts (MEFs) lacking key apoptotic molecules. These included MEFs lacking Apaf-1 and caspase 9 (molecules that are required to form the apoptosome), MEFs lacking caspase 3 (an important executor caspase), and MEFs deficient in apoptosis signal-regulating kinase 1 (ASK1; a molecule downstream in death signaling pathways that lead to apoptosis) (Green 2003; Nagai et al. 2007 ). Figure 1 shows that Structure 1. Structures of ET-18-OCH3, Gln, and 2-deoxy-C-Glc.
ET-18-OCH 3 and Gln had a similar effect in inhibiting the growth of wild-type MEFs. Both compounds were equally effective in killing the cells at concentrations greater than 10 mmol/L. ET-18-OCH 3 was ineffective in inhibiting growth and killing ASK1 -/-, caspase 3 -/-, Apaf1 -/-, and caspase 9 -/-MEFs. In contrast, Gln was able to kill Apaf1 -/-, caspase 9 -/-, caspase 3 -/-, and ASK1 -/-MEFs at concentrations similar to those that killed wild-type cells. These results suggest that Gln-induced MEF cell death does not depend on the activation of caspases 3 or 9.
The above results, which indicate that Gln does not require caspase 9 or 3 for its cytotoxic activity, do not preclude a role for other caspases. To investigate if caspases are involved in Gln-induced cell death, we examined the effect of Gln on activation of caspases in cells. After proliferating cells were incubated with 9 mmol/L Gln for 12 h, the increase in caspase activity was measured by the Casp-GLOW assay. Relative to controls, incubation with Gln increased caspase activity 3-to 4-fold in wild-type MEF and ASK1-/-cells and about 1.5-to 2-fold in caspase 9 -/-and caspase 3 -/-MEFs. To investigate whether the increase in caspase activity plays a role in Gln-mediated cell death, the toxic effect of Gln was examined in the presence of the caspase inhibitor, Z-VAD-FMK. ASK1 -/-cells were used for these studies because they, along with wild-type MEFs, showed the highest increase in caspase activity following incubation with Gln. Experiments were initially conducted to investigate the effectiveness of Z-VAD-FMK in inhibiting Gln-induced caspase activation. ASK1 -/-cells were incubated with 2 mmol/L Z-VAD-FMK for 24 h. The medium was replaced with 10 mmol/L Gln and 2 mmol/L Z-VAD-FMK for 12 h. The activation of caspases in the cells was measured by the CaspGLOW assay. The results showed that, while addition of Gln resulted in a 3.8-fold increase in caspase activation relative to controls, the presence of Z-VAD-FMK inhibited the activation by 87% (Fig. 2 insert) . Subsequently, these incubation conditions were utilized to investigate the effect of inhibiting caspases on the toxicity of Gln in ASK1 -/-cells. After incubation of the cells with Gln in the presence or absence of Z-VAD-FMK, the viability of the cells was assessed by using the ToxiLight assay. Figure 2 shows that the addition of Z-VAD-FMK did not protect the cells from the toxic effects of Gln. These studies show that the toxic effects of Gln were not dependent on caspase activation.
Gln-induced cell death is not mediated by caspaseindependent apoptosis
It is well established that there are several pathways to cell death other than the classical caspase-mediated apoptosis (Broker et al. 2005) . Since Gln-induced cell death is not mediated by caspase-dependent apoptosis, we investigated whether the cells were dying via caspase-independent apoptosis. A common early initiating event in apoptosis is the loss of mitochondrial membrane potential owing to the collapse of the mitochondrial permeability transition. This loss of membrane potential is closely associated with irreversible cell death via apoptosis (Susin et al. 1996) . To investigate the role of caspase-independent apoptosis in Gln-induced cell death, ASK1 -/-and ATG5 -/-cells were incubated with Gln under conditions known to kill a significant proportion of the cells. ATG5 is a key molecule in the elongation phase of autophagy, and cells deficient in ATG5 do not undergo autophagy (Mizushima et al. 2001) . When the ASK1 -/-cells were treated for 10 h with 10 mmol/L Gln and when the ATG5 -/-cells were treated for 24 h with 15 mmol/L Gln, a large proportion of the cells were rounded up, and floating dead cells were observed. At the end of the incubation periods, the mitochondrial membrane potential was measured with the JC-1 reagent. The results obtained are shown in Fig. 3 . While the mitochondria of dead ASK1 -/-cells were not stained by the dye, staining of mitochondria was observed even in rounded dying cells. A similar staining of the mitochondria of dying cells was observed in the ATG5 wild-type MEFs incubated with Gln for 24 h. The results show that, in cells incubated with Gln, the mitochondrial membrane potential is maintained until very late in the dying process. Since our results demonstrated that caspase-dependent apoptosis was not involved in Glninduced cell death and loss of mitochondrial membrane potential occurs late in the dying process, apoptosis is not the means via which Gln kills cells.
Gln induces an increase in LC3-II levels in cells
Autophagy has been recognized as a potential mechanism for inducing cell death (Levine and Yuan 2005) . Since Gln does not kill cells by apoptosis, studies were conducted to investigate whether Gln induces autophagy in cells. LC3 is the human homolog of yeast ATG8, a protein that is essential for autophagy (Kabeya et al. 2000) . LC3 is processed to LC3-I in the cytosol and converted to LC3-II, which associates with the growing autophagosome. The generation of LC3-II, assessed by Western blotting or microscopically as LC3-II puncta, is indicative of its association with autophagosomes and is a sensitive and specific assay for autophagy (Mizushima 2004) .
Autophagy was initially assayed by monitoring the levels of LC3-II by Western blot analysis in cell lysates. Cell lines were incubated with Gln for the specified periods, washed, and cell lysates were prepared. The cell lysates were subjected to Western blot analysis with LC3 antibodies. An increase in LC3-II levels was observed in wild-type, caspase 3 -/-, and ASK 1 -/-MEFs as well as in A549 lung cancer and BT549 breast cancer cells (Fig. 4) . The results suggest that Gln was able to induce or stimulate autophagy in a wide variety of cells.
The time course of the appearance of LC3-II was investigated. LC3-II was observed as early as 1 h after incubation of caspase 3 -/-and wild-type MEFs with the compound, and it increased in a time-dependent manner (Fig. 4B) . In ASK1 -/-cells, LC3-II was detected as early as 45 min after the addition of 7.5 mmol/L Gln to the cells. The results are consistent with the stimulation of autophagy by Gln in a time-dependent manner.
Bafilomycin inhibits the fusion of autophagosomes with lysosomes, resulting in the accumulation of autophagosomes in cells (Yamamoto et al. 1998) . We investigated the effect of bafilomycin on the LC3-II levels in ASK1 -/-cells incubated with Gln. Figure 4C shows that the levels of LC3-II were higher in cells incubated with bafilomycin compared with control cells that were not incubated with bafilomycin. The LC3-II levels were also higher when cells were incu- bated with both Gln and bafilomycin than when cells were incubated with Gln alone. These results indicate that inhibition of autophagosome association with lysosomes by bafilomycin leads to the buildup of autophagosomes in cells incubated with Gln. Hence, LC3-II levels are increased.
Gln increases LC3-II levels in ATG5 wild-type but not in ATG5-deficient cells
To examine if the Gln-induced appearance of LC3-II was restricted to autophagy-competent cells, we compared the effect of Gln on LC3-II levels in ATG5 wild-type cells and ATG5 -/-MEFs, and we also studied the effect of bafilomycin on the levels of LC3-II that accumulated in the cells. ATG5 wild-type and ATG5 -/-cells were incubated with or without Gln in the presence or absence of bafilomycin. As shown in Fig. 4C , the addition of Gln increased LC3-II levels in wild-type cells, as did incubation of the cells with bafilomycin. In cells incubated with Gln and bafilomycin, the levels of LC3-II were higher than those observed with Gln alone. In contrast, LC3-II was not formed in ATG5 -/-cells. Thus, ATG5 is required for Gln-induced production of LC3-II.
Gln induces the formation of GFP-LC3 puncta in CHO cells
Another widely accepted assay used to monitor autophagy is the formation of GFP-LC3 puncta, which represent preautophagosome and autophagosome structures in cells (Mizushima 2004) . We investigated whether Gln induced GFP-LC3 puncta in CHO cells stably expressing GFP-LC3 (Fass et al. 2006 ). The cells were incubated with or without Gln in the presence or absence of bafilomycin. Experiments were also conducted with cells incubated with rapamycin, a known inducer of autophagy (Sarkar et al. 2005 ). The cells were fixed and examined by fluorescence microscopy. Figure 5 shows that incubation with Gln generated GFP-LC3 puncta. Cells incubated with rapamycin also resulted in generation of GFP-LC3 puncta. In the presence of bafilomycin, there was an increase in the number of punctate structures compared with cells without bafilomycin. These results are consistent with the view that incubation of cells with Gln results in the formation of autophagosomes in the cells; however, incubation of cells with Gln in the presence of bafilomycin caused the accumulation of the vesicles in the cells because fusion of the autophagosomes to the lysosomes was inhibited.
Fig. 3. Loss of mitochondrial membrane potential is a late event in 1-O-hexadecyl-2-O-methyl-3-O-(2'-amino-2'-deoxy-b-D-glucopyranosyl)-
sn-glycerol (Gln)-induced cell death. ASK1 -/-mouse embryonic fibroblasts and ATG5 wild-type mouse embryonic fibroblasts were cultured on cover slips. ASK1 -/-cells were incubated with (III) or without (I) 9 mmol/L Gln for 10 h, and ATG5 wild-type cells were incubated with (IV) or without (II) 15 mmol/L Gln for 24 h. At the end of the incubation period, JC-1 reagent was added, and the cells were viewed under a fluorescence microscope. Bars, 20 mm.
Gln-induced autophagy is not dependent on inhibition of mTOR
Inhibition of mTOR has been identified as a key initiating event in starvation-induced autophagy (Levine and Yuan 2005) . To investigate if Gln-induced autophagy is dependent on the inhibition of mTOR, we investigated whether incubation of cells with Gln inhibits the activity of mTOR. mTOR activity was assessed by examining the effect of the com- 
. 1-O-Hexadecyl-2-O-methyl-3-O-(2'-amino-2'-deoxy-b-D-glucopyranosyl)-sn-glycerol (Gln) induces an increase in LC3-II levels in cells. (A)
Proliferating ASK1 -/-, caspase 3 -/-, and wild-type mouse embryonic fibroblasts (MEFs), A549, and BT549 cells were incubated with 7.5 mmol/L Gln for 6 h (ASK1 -/-, caspase 3 -/-wild-type (WT) MEFs) or 24 h (A549, BT549). The cells were washed and harvested, and cell lysates were prepared in the presence of protease inhibitors. Samples were run on SDS-PAGE gels and subjected to Western blot analysis with an LC3 antibody obtained from Dr. Yoshimori. (B) Time course of the generation of LC3-II by Gln in wild-type, caspase 3 -/-, and ASK1 -/-MEFs. Proliferating cells were incubated with 7.5 mmol/L Gln for various times. At the end of the incubation, the cells were treated as described above. (C) Proliferating ASK1 -/-, ATG5 wild-type, and ATG5 -/-cells were incubated with or without 7.5 mmol/L or 10 mmol/L Gln for 6 h in the presence or absence of bafilomycin (200 nmol/L). At the end of the incubation, the cells were washed and harvested, and cell lysates were prepared in the presence of protease inhibitors. Immunoblotting was performed with an LC3 antibody from Novus Biologicals. The results presented are representative of blots obtained from 3 independent experiments. pound on the activity of its downstream substrates ribosomal S6 protein kinase, which phosphorylates ribosomal S6 protein, and eukaryotic initiation factor 4E-binding protein 1 (4E-BP1) (Sarkar et al. 2005) . The activation of these proteins was assessed with phospho-specific antibodies to S6-protein and 4E-BP1. The results, which are shown in Fig. 6A , revealed that incubation of the cells with Gln had no effect on the phosphorylation of S6 protein or 4E-BP1.
These results suggest that Gln does not stimulate autophagy by inhibiting mTOR.
Gln-induced autophagy is not inhibited by class 3 PI3 kinase inhibitors
The mechanism of starvation-induced autophagy requires the generation of phosphatidylinositol 3-phosphate by class 3 PI3K (Backer 2008) . This lipid kinase is inhibited by 3-MA and wortmannin, and these 2 inhibitors have been used extensively as autophagy inhibitors (Rubinsztein et al. 2007) . Recent reports have shown that autophagy may be induced in a class 3 PI3K-independent manner (Sarkar et al. 2005; Chu et al. 2007 ). The involvement of class 3 PI3K in Gln-induced autophagy was investigated by examining the effects of 3-MA and wortmannin on the Gln-induced generation of LC3-II in ASK 1 -/-cells. Cells were pre-incubated with 3-MA for 12 h and subsequently with 3-MA and Gln for 12 h. Wortmannin was added simultaneously with Gln for the incubation period. Cell lysates were prepared, and autophagy was assessed as the generation of LC3-II by Western blot analysis. Figure 6B shows that 3-MA and wortmannin did not abrogate the Gln-induced production of LC3-II. Thus, Gln-induced autophagy is independent of the activation of class 3 PI3K.
Autophagy is not essential for Gln-induced cell death
Because enhanced autophagy leads to cell death and Gln induces autophagy, we investigated whether Gln induces cell death via autophagy. We compared the toxic effect of Gln on autophagy-competent ATG5 wild-type cells and autophagy-incompetent ATG5 -/-MEFs. Gln inhibited the growth of both ATG5 wild-type and ATG5 -/-cells (Fig. 7) . While ATG5 wild-type cells were slightly more sensitive to Gln, growth cessation for both cell types was observed after incubation with 12.5 mmol/L Gln for 24 h. Under these incubation conditions, 42% of the ATG5 wildtype cells were viable whereas about 60% of the ATG5 -/-cells were viable, as assessed by the ToxiLight assay Proliferating ASK 1 -/-cells were incubated with or without 7.5 mmol/L Gln for 6 h in the presence or absence of 3-methyladenine (3-MA) (10 mmol/L) or wortmannin (0.1 mmol/L). In experiments with 3-MA, the cells were pre-incubated with 3-MA for 12 h prior to the addition of 3-MA and Gln. At the end of the incubation, the cells were washed and harvested, and the cell lysates were prepared in the presence of protease inhibitors. Immunoblotting was performed with anti-phospho-4P-BP1 or anti-phospho-S6 protein (S6P) (A) and LC3 antibodies from Novus Biologicals (B). The results presented are representative of blots obtained from 3 independent experiments.
but not 2-deoxy-C-Glc inhibits proliferation and is toxic to ATG5 wild-type, ATG5 -/-and Chinese hamster ovary (CHO) green fluorescent protein (GFP)-LC3 cells. Exponentially growing cells in 48-well plates were incubated with or without Gln or 2-deoxy-C-Glc for 24 h. The increase in the number of cells over the number present on the day of addition of the drugs was determined by use of the CyQuant assay. The results are expressed as means of the percentage of the values of the controls ± standard deviation of 6 independent experiments for (A) ATG5 wild-type and ATG5 -/-cells and (B) CHO-GFP-LC3 cells. (C) ATG5 wild-type, ATG5 -/-, and CHO-GFP-LC3 cells were grown in 96-well clear-bottomed white plates. Gln was added when the cells were in log phase. After 24 h, the level of adenylate kinase present in the medium was measured by use of the ToxiLight assay and expressed as a percentage of the total activity present in the media and cells. Data are presented as the means ± standard deviation of 8 independent experiments. (Fig. 7) . At concentrations greater than 15 mmol/L Gln, 100% of the cells in both groups were dead. These results indicate that, while induction of autophagy by Gln may enhance the sensitivity of the cells to Gln, it is not required for Gln-induced toxicity or antiproliferation.
Gln induces the generation of cytoplasmic vacuoles in cells
The results from our studies indicated that the toxic effect of Gln was not mediated by autophagy or apoptosis. Thus, Gln may kill cells via other types of caspase-independent cell death (Broker et al. 2005; Tang et al. 2008) . During the course of our experiments, morphological examination of the AEL-treated cells revealed striking differences between the cells treated with Gln and those treated with ET-18-OCH 3 . While the morphology of ASK 1 -/-cells incubated with ET-18-OCH 3 was not significantly different from that of control cells, cells treated with Gln displayed large numbers of cytoplasmic vacuolar structures (Fig. 8) . The vacuoles started off as small vesicles and became progressively larger with time. The appearance of vacuoles was not limited to MEFs (caspase 3 -/-, caspase 9 -/-, Apaf1 -/-, ASK1 -/-, ATG5 wild-type, and ATG5 -/-cells); they were also observed in mammalian cancer cells, including MDA-MB-231 and BT549 (breast), DU145 (prostate), A549 (lung), and CHO cells, indicating that this was a phenomenon observed in cells incubated with Gln. Significantly, the observed production of the vesicles in ATG5 -/-cells, which are autophagy incompetent, indicates that the vacuolation process is independent of autophagy. 
Generation of cytoplasmic vacuoles correlates with toxicity
The observation that Gln was almost as toxic to autophagy-incompetent ATG5 -/-MEFs as it was to autophagycompetent ATG5 wild-type cells, and that Gln treatment generated vacuoles in both cell types, prompted us to investigate the possible involvement of vacuole production in cell death. We observed that low concentrations of Gln (below toxic levels) generated vacuoles initially, but they disappeared with time, and that the treated cells were indistinguishable from the control cells and were are able to proliferate. To investigate if there was a correlation between toxicity and the formation of vacuoles, we used 2-deoxy-CGlc, a GAEL analog that was previously demonstrated to be non-toxic in cancer cell lines . The antiproliferation and toxic effect of 2-deoxy-C-Glc on ATG5 -/-MEFs and CHO-GFP-LC3 cells was initially established. 2-Deoxy-C-Glc had a minimal effect on the proliferation of ATG5 -/-cells (Fig. 7A ) and CHO-GFP-LC3 cells (Fig. 7B) even at a concentration of 20 mmol/L. Use of the ToxiLight assays revealed that cells treated with 20 mmol/L of 2-deoxy-C-Glc for 24 h were as viable as the control cells. In contrast, Gln inhibited cell growth and was toxic to ATG5 -/-cells ( Fig. 7A and Fig. 7C ). Gln was also toxic to CHO-GFP-LC3 cells (Fig. 7B) ; all the cells were dead after incubation with 15 mmol/L for 24 h. Examination of the morphology of the cells incubated with 2-deoxy-CGlc revealed that no vacuoles were formed (data not shown). Thus, 2-deoxy-C-Glc did not generate vacuoles and was not toxic.
The ability of 2-deoxy-C-Glc to induce GFP-LC3 puncta in CHO-GFP-LC3 cells was examined. The compound induced GFP-LC3 puncta in the cells (Fig. 9) . The ability of Gln to induce GFP-LC3 puncta was shown in Fig. 5 . Thus, Gln and 2-deoxy-C-Glc appear to induce autophagy, but while 2-deoxy-C-Glc does not induce vacuoles and is not toxic, Gln is toxic to both autophagy-competent and autophagy-incompetent cells and induces the formation of vacuoles in both cell types.
Gln-induced vacuoles are acidic
In light of the potential role of the vacuoles generated by Gln in the toxicity of GAELs, a preliminary characterization of the nature of the vacuoles was conducted. To determine whether the vacuoles were acidic in nature, we used acridine orange and lysotracker probes, which accumulate in acidic structures. In the presence of Gln there was a large increase in acridine orange fluorescence intensity relative to that in control cells (Fig. 10A ). Increased staining with lysotracker was also observed (Fig. 10B) . These results indicate that the vacuoles formed in response to Gln are acidic.
Discussion
The results of studies reported herein have identified GAELs as small molecules that may induce autophagy. In this study, Gln stimulated an increase in LC3-II levels in a variety of cell types and also induced GFP-LC3 puncta in CHO-GFP-LC3 cells. The increase in LC3-II levels was observed in ATG5 wild-type but not in ATG 5 -/-cells. The apparent autophagy-inducing effect of Gln appears to be a general characteristic of GAELs, because the generation of GFP-LC3 puncta has been observed with other GAELs (G. Arthur, P. Samadder, R. Bittman 2008, unpublished observations) including 2-deoxy-C-Glc, a non-toxic GAEL.
The mechanism of induction of autophagy by Gln appears to be distinct from the mechanisms of starvation-induced autophagy. It is mTOR-independent, because Gln was able to generate LC3-II without inhibition of mTOR, as assessed by the phosphorylation state of S6 phosphate protein and 4E-BP1, downstream substrates of mTOR (Sarkar et al. 2005) . Another difference between GAEL-induced autophagy and starvation-induced autophagy is that GAELinduced autophagy is not abrogated by 3-MA and wortmannin, 2 widely used inhibitors of starvation-induced autophagy. Gln-induced autophagy is also distinct from lithium-induced autophagy, which is mTOR independent but Vps34 dependent. Induction of autophagy via Vps34-independent mechanisms has been reported , and alternative mechanisms for generating phosphatidylinositol-3-phosphate (PI(3)P) other than via Beclin1/Vps34 have been postulated Backer 2008) . Although detailed mechanisms for the induction of autophagy by GAEL remain to be established, because our data indicate that it is both mTOR independent and not inhibited by class 3 PI3K inhibitors, we conclude that the regulatory mechanism is distinct from those that have been currently reported. It is worth noting that even the regulation of the well-studied starvation-induced autophagy is still very poorly understood. While our results are consistent with GAEL-induced autophagy, we cannot discount the possibility that the GAEL-stimulated production of LC3-II observed and the generation of GFP-LC3 puncta could result from an effect of the compounds on the flux of autophagy in cells.
Gln is a cytotoxic compound that kills cancer cells. While autophagy has been established as a pathway that can lead to cell death, our studies revealed that induction of autophagy by Gln is not essential for the cytotoxic effects of GAELs, but may contribute to greater susceptibility of cells to Gln. Gln effectively inhibited the proliferation and killed ATG5 -/-MEFs that do not undergo autophagy at concentrations of the same order of magnitude that affected the au- tophagy-competent ATG5 wild-type cells. In addition, we demonstrated that 2-deoxy-C-Glc was able to induce GFP-LC3 puncta in cells without the associated toxicity.
Our studies on the possible mode of Gln-induced cell death led to the conclusion that the cell death was not mediated by autophagy, and unlike the alkyl-lysophospholipids that kill cells by activating caspases to induce apoptosis (Cuvillier et al. 1999) , the toxic effects of Gln were independent of caspases. Gln killed cells lacking Apaf-1 and caspase 9, molecules required for the formation of the apoptosome, and cell death was not prevented by the pan caspase inhibitor Z-VAD-FMK. Furthermore, the late loss of mitochondrial membrane potential in Gln-treated cells indicates that Gln kills cells through a mechanism that does not involve mitochondria. It is interesting that Gln activated caspases but killed cells in an apparent caspase-independent manner. This phenomenon has been reported in cell death mediated by CD437 and a polyamine oxidase inhibitor (Dai et al. 1999; Zang et al. 2001) . Several caspase-independent cell death pathways, such as oncosis, necrosis, mitotic catastrophe, and paraptosis, have been reported (Sperandio et al. 2004; Broker et al. 2005; Tang et al. 2008) . The ability of Gln to kill Apaf-1 and caspase 9 null cells indicates that Gln toxicity does not require apoptosome formation and subsequent caspase activation.
Paraptosis is characterized by cytoplasmic vacuolation, rounding of cells, and maintenance of membrane integrity. In cells incubated with Gln, extensive cytoplasmic vacuoles were formed, and the cells rounded up. These observations suggest that Gln kills cells by a paraptosis-like phenomenon rather than by oncosis, necrosis, or mitotic catastrophe. Mitochondrial membrane potential loss is characteristic of paraptosis cell death activated by TAJ-TROY (Wang et al. 2004) , but this did not appear to be the case in Gln-induced paraptosis, in which mitochondrial membrane potential was unaffected late into the dying process. Sperandio et al. (2004) also classified mitochondrial changes as late events in paraptosis.
Very little is known about the regulation of paraptosis, although a number of molecules that might participate in regulating paraptosis have recently been reported (Wang et al. 2004; Sperandio et al. 2004) . It has been proposed that paraptosis may require caspase 9 protein acting independently of apoptosome formation (Sperandio et al. 2004) . Whether this is a universal requirement or a specific requirement for the initiating signal remains to be established. However, Gln effectively killed caspase 9 null cells, and vacuolation was also observed in these cells. Thus, either another molecule substitutes for caspase 9 to induce paraptosis in the caspase 9 null cells or Gln-induced paraptosis may not require caspase 9. While vacuoles in paraptosis are thought to be derived from endoplasmic reticulum or mitochondria (Sperandio et al. 2004; Wang et al. 2004) , our studies revealed that the vacuoles induced by Gln were acidic and may have a lysosomal component. Perturbation of lysosomal permeability appears to be a key feature of caspase-independent cell death (Broker et al. 2005; Tang et al. 2008) . The large increase in acidic vacuoles in Glntreated cells hints at the possible involvement of lysosomal perturbation in Gln-induced cell death. Our studies do not rule out the generation of neutral or basic vacuoles by Gln.
It would also be of interest to elucidate how the compounds induce the formation of the vacuoles as well as the mechanism via which generation of the vacuoles leads to cell death.
